Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gluconeogenesis | 14 | 2024 | 107 | 2.460 |
Why?
|
| Insulin Resistance | 16 | 2023 | 638 | 1.640 |
Why?
|
| Glucose | 17 | 2024 | 869 | 1.440 |
Why?
|
| Lipodystrophy | 4 | 2023 | 34 | 0.620 |
Why?
|
| Energy Metabolism | 4 | 2024 | 766 | 0.600 |
Why?
|
| Insulin | 11 | 2023 | 1197 | 0.580 |
Why?
|
| Glycogenolysis | 3 | 2018 | 9 | 0.570 |
Why?
|
| Blood Glucose | 16 | 2024 | 1113 | 0.520 |
Why?
|
| Parenteral Nutrition, Total | 3 | 2011 | 114 | 0.510 |
Why?
|
| Bile Acids and Salts | 4 | 2022 | 233 | 0.500 |
Why?
|
| Parenteral Nutrition | 6 | 2022 | 183 | 0.490 |
Why?
|
| Infant, Premature | 4 | 2023 | 798 | 0.440 |
Why?
|
| Fat Emulsions, Intravenous | 4 | 2021 | 71 | 0.430 |
Why?
|
| Digestion | 3 | 2020 | 37 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2024 | 1224 | 0.420 |
Why?
|
| Hyperglycemia | 4 | 2018 | 218 | 0.410 |
Why?
|
| Glycine | 4 | 2024 | 160 | 0.390 |
Why?
|
| Ghrelin | 1 | 2012 | 51 | 0.390 |
Why?
|
| Bariatric Surgery | 2 | 2024 | 113 | 0.380 |
Why?
|
| Cholestasis | 3 | 2021 | 148 | 0.350 |
Why?
|
| Metformin | 2 | 2024 | 148 | 0.350 |
Why?
|
| Deuterium Oxide | 2 | 2020 | 17 | 0.350 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2020 | 75 | 0.330 |
Why?
|
| Fasting | 4 | 2022 | 296 | 0.320 |
Why?
|
| Obesity, Morbid | 2 | 2022 | 184 | 0.320 |
Why?
|
| Fatty Acids | 3 | 2020 | 340 | 0.320 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2010 | 191 | 0.320 |
Why?
|
| Methionine | 4 | 2011 | 102 | 0.320 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 75 | 0.310 |
Why?
|
| Liver Diseases | 3 | 2019 | 362 | 0.300 |
Why?
|
| Premature Birth | 3 | 2022 | 379 | 0.300 |
Why?
|
| Starch | 3 | 2020 | 24 | 0.300 |
Why?
|
| alpha-Glucosidases | 2 | 2020 | 26 | 0.290 |
Why?
|
| Vitamin E | 2 | 2019 | 64 | 0.290 |
Why?
|
| Liver | 6 | 2021 | 1727 | 0.290 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 353 | 0.270 |
Why?
|
| Soybean Oil | 4 | 2021 | 65 | 0.270 |
Why?
|
| Sucrase-Isomaltase Complex | 2 | 2017 | 19 | 0.260 |
Why?
|
| Carbon Isotopes | 5 | 2020 | 271 | 0.250 |
Why?
|
| Animals, Newborn | 6 | 2023 | 988 | 0.250 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2024 | 11 | 0.240 |
Why?
|
| Benzoic Acid | 1 | 2024 | 3 | 0.230 |
Why?
|
| Dietary Carbohydrates | 2 | 2016 | 117 | 0.230 |
Why?
|
| Thermogenesis | 1 | 2024 | 44 | 0.230 |
Why?
|
| Enteral Nutrition | 3 | 2023 | 250 | 0.230 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 77 | 0.230 |
Why?
|
| Adipose Tissue, White | 1 | 2024 | 79 | 0.230 |
Why?
|
| Phytosterols | 2 | 2021 | 27 | 0.220 |
Why?
|
| Swine | 6 | 2023 | 1155 | 0.220 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2022 | 5 | 0.210 |
Why?
|
| Leptin | 2 | 2023 | 211 | 0.210 |
Why?
|
| Hypoglycemic Agents | 3 | 2024 | 423 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 4342 | 0.210 |
Why?
|
| Glutathione | 3 | 2021 | 193 | 0.210 |
Why?
|
| Adipose Tissue | 3 | 2020 | 465 | 0.200 |
Why?
|
| Animals | 21 | 2024 | 33692 | 0.200 |
Why?
|
| Sus scrofa | 4 | 2019 | 122 | 0.200 |
Why?
|
| Exercise | 2 | 2019 | 809 | 0.190 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2022 | 58 | 0.190 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2020 | 68 | 0.180 |
Why?
|
| Aging | 3 | 2024 | 1173 | 0.180 |
Why?
|
| Male | 24 | 2024 | 59898 | 0.180 |
Why?
|
| Acetylcysteine | 1 | 2021 | 73 | 0.180 |
Why?
|
| Muscle Strength | 1 | 2021 | 75 | 0.180 |
Why?
|
| Receptor, Insulin | 1 | 2020 | 67 | 0.180 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2018 | 136 | 0.180 |
Why?
|
| Incretins | 1 | 2020 | 25 | 0.170 |
Why?
|
| Lipolysis | 1 | 2020 | 82 | 0.170 |
Why?
|
| Lipogenesis | 1 | 2020 | 59 | 0.170 |
Why?
|
| Oxidation-Reduction | 6 | 2020 | 445 | 0.170 |
Why?
|
| Gastrectomy | 1 | 2020 | 89 | 0.170 |
Why?
|
| Homeostasis | 2 | 2021 | 681 | 0.170 |
Why?
|
| Barth Syndrome | 1 | 2019 | 1 | 0.170 |
Why?
|
| Humans | 34 | 2024 | 122991 | 0.160 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2010 | 77 | 0.160 |
Why?
|
| Female | 25 | 2024 | 65304 | 0.160 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2011 | 167 | 0.160 |
Why?
|
| Phospholipids | 1 | 2019 | 107 | 0.160 |
Why?
|
| Fatty Liver | 1 | 2020 | 176 | 0.160 |
Why?
|
| Alanine | 3 | 2023 | 181 | 0.160 |
Why?
|
| Rifampin | 1 | 2019 | 145 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 384 | 0.160 |
Why?
|
| Antigens, CD | 1 | 2020 | 420 | 0.150 |
Why?
|
| Proglucagon | 1 | 2017 | 5 | 0.150 |
Why?
|
| Infant, Newborn | 6 | 2023 | 8068 | 0.150 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 2017 | 5 | 0.150 |
Why?
|
| Sucrase | 1 | 2017 | 22 | 0.150 |
Why?
|
| Homocysteine | 4 | 2011 | 121 | 0.150 |
Why?
|
| Glucagon | 3 | 2017 | 185 | 0.150 |
Why?
|
| Intestines | 1 | 2021 | 571 | 0.150 |
Why?
|
| Dietary Supplements | 2 | 2021 | 471 | 0.140 |
Why?
|
| Isothiocyanates | 1 | 2017 | 13 | 0.140 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2017 | 36 | 0.140 |
Why?
|
| Gastrointestinal Agents | 1 | 2017 | 60 | 0.140 |
Why?
|
| Leucine | 3 | 2023 | 309 | 0.130 |
Why?
|
| Bicycling | 1 | 2016 | 39 | 0.130 |
Why?
|
| Cognition | 1 | 2021 | 736 | 0.130 |
Why?
|
| Adult | 14 | 2022 | 28978 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2021 | 796 | 0.130 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2016 | 49 | 0.130 |
Why?
|
| Thinness | 1 | 2016 | 68 | 0.130 |
Why?
|
| Inflammation | 2 | 2021 | 1399 | 0.130 |
Why?
|
| Models, Biological | 3 | 2016 | 1442 | 0.130 |
Why?
|
| Serine | 1 | 2016 | 174 | 0.120 |
Why?
|
| Microbiota | 1 | 2020 | 392 | 0.120 |
Why?
|
| Diet, Protein-Restricted | 1 | 2016 | 82 | 0.120 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 208 | 0.120 |
Why?
|
| Mice | 8 | 2024 | 17468 | 0.110 |
Why?
|
| Swine Diseases | 1 | 2014 | 36 | 0.110 |
Why?
|
| Calorimetry, Indirect | 3 | 2021 | 60 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 226 | 0.110 |
Why?
|
| Amino Acids | 3 | 2023 | 651 | 0.110 |
Why?
|
| Fish Oils | 3 | 2021 | 82 | 0.100 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2023 | 162 | 0.100 |
Why?
|
| Food Deprivation | 1 | 2012 | 29 | 0.100 |
Why?
|
| Receptors, Ghrelin | 1 | 2012 | 28 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 614 | 0.100 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2011 | 5 | 0.100 |
Why?
|
| Muscle, Skeletal | 3 | 2023 | 939 | 0.090 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2011 | 39 | 0.090 |
Why?
|
| Young Adult | 6 | 2021 | 8840 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 94 | 0.090 |
Why?
|
| Adolescent | 8 | 2024 | 19030 | 0.090 |
Why?
|
| Gestational Age | 2 | 2015 | 1115 | 0.090 |
Why?
|
| Emulsions | 2 | 2021 | 65 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2011 | 214 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2024 | 3259 | 0.090 |
Why?
|
| Isotope Labeling | 3 | 2020 | 102 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2015 | 519 | 0.090 |
Why?
|
| Colitis | 1 | 2011 | 152 | 0.080 |
Why?
|
| Amino Acids, Sulfur | 1 | 2009 | 15 | 0.080 |
Why?
|
| Craniosynostoses | 1 | 2011 | 131 | 0.080 |
Why?
|
| Abdomen | 1 | 2009 | 130 | 0.080 |
Why?
|
| Birth Weight | 1 | 2010 | 335 | 0.080 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 2 | 2021 | 35 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 407 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 670 | 0.080 |
Why?
|
| Methenamine | 1 | 2008 | 7 | 0.080 |
Why?
|
| Intestinal Mucosa | 2 | 2013 | 765 | 0.080 |
Why?
|
| Lactation | 1 | 2009 | 187 | 0.080 |
Why?
|
| Body Water | 1 | 2008 | 88 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2013 | 3710 | 0.070 |
Why?
|
| Glucose Tolerance Test | 2 | 2018 | 203 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 3358 | 0.070 |
Why?
|
| Radioactive Tracers | 1 | 2006 | 20 | 0.070 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 46 | 0.070 |
Why?
|
| Obesity | 3 | 2024 | 2226 | 0.060 |
Why?
|
| Mitochondria | 2 | 2021 | 682 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2007 | 208 | 0.060 |
Why?
|
| Triglycerides | 2 | 2020 | 561 | 0.060 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2024 | 5 | 0.060 |
Why?
|
| Dioxoles | 1 | 2024 | 10 | 0.060 |
Why?
|
| Critical Illness | 1 | 2009 | 595 | 0.060 |
Why?
|
| Biomarkers | 3 | 2021 | 2940 | 0.060 |
Why?
|
| Uncoupling Protein 1 | 1 | 2024 | 29 | 0.060 |
Why?
|
| Hippurates | 1 | 2024 | 6 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2009 | 900 | 0.060 |
Why?
|
| Liraglutide | 1 | 2024 | 13 | 0.060 |
Why?
|
| Pregnancy | 4 | 2021 | 7112 | 0.060 |
Why?
|
| Palmitates | 1 | 2023 | 19 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2022 | 1542 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 2848 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1101 | 0.060 |
Why?
|
| Glycerol | 1 | 2023 | 90 | 0.060 |
Why?
|
| Child | 6 | 2021 | 24144 | 0.060 |
Why?
|
| Carbon | 1 | 2023 | 87 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2023 | 140 | 0.050 |
Why?
|
| Cholic Acid | 1 | 2022 | 17 | 0.050 |
Why?
|
| Diet | 3 | 2020 | 1125 | 0.050 |
Why?
|
| Glycine Agents | 1 | 2021 | 8 | 0.050 |
Why?
|
| Haploinsufficiency | 1 | 2022 | 247 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2021 | 49 | 0.050 |
Why?
|
| Keto Acids | 1 | 2020 | 55 | 0.050 |
Why?
|
| Endothelium | 1 | 2021 | 71 | 0.050 |
Why?
|
| Cross-Over Studies | 2 | 2012 | 310 | 0.050 |
Why?
|
| Peptide YY | 1 | 2020 | 18 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 154 | 0.040 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2020 | 19 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 25929 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2012 | 533 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3005 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 169 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 428 | 0.040 |
Why?
|
| Hyperbilirubinemia | 1 | 2019 | 41 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 417 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 666 | 0.040 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 59 | 0.040 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 69 | 0.040 |
Why?
|
| Palmitic Acid | 1 | 2018 | 35 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2021 | 381 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 426 | 0.040 |
Why?
|
| Amino Acids, Essential | 1 | 2018 | 26 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 4507 | 0.040 |
Why?
|
| Tritium | 2 | 2009 | 173 | 0.040 |
Why?
|
| Glucose Clamp Technique | 1 | 2018 | 79 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 250 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 1294 | 0.040 |
Why?
|
| Shrews | 1 | 2017 | 5 | 0.040 |
Why?
|
| DNA Damage | 1 | 2021 | 506 | 0.040 |
Why?
|
| Gene Expression | 2 | 2014 | 1569 | 0.040 |
Why?
|
| Receptors, Glucagon | 1 | 2017 | 29 | 0.040 |
Why?
|
| Sulfoxides | 1 | 2017 | 10 | 0.040 |
Why?
|
| India | 1 | 2018 | 217 | 0.040 |
Why?
|
| Methylation | 2 | 2009 | 227 | 0.040 |
Why?
|
| China | 1 | 2018 | 236 | 0.040 |
Why?
|
| Kinetics | 2 | 2009 | 1313 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2018 | 196 | 0.030 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2017 | 66 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 1386 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 423 | 0.030 |
Why?
|
| Glycogen | 1 | 2016 | 63 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2017 | 102 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 316 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2016 | 28 | 0.030 |
Why?
|
| Athletes | 1 | 2016 | 59 | 0.030 |
Why?
|
| Energy Intake | 1 | 2018 | 487 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 108 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 111 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2017 | 671 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 359 | 0.030 |
Why?
|
| Cholestenones | 1 | 2014 | 7 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2801 | 0.030 |
Why?
|
| Olive Oil | 1 | 2014 | 22 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2014 | 40 | 0.030 |
Why?
|
| Plant Oils | 1 | 2014 | 32 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 465 | 0.030 |
Why?
|
| Postprandial Period | 1 | 2013 | 77 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1069 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6022 | 0.030 |
Why?
|
| Algorithms | 2 | 2009 | 1595 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 4704 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 849 | 0.020 |
Why?
|
| Sex Factors | 1 | 2016 | 1254 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2779 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2391 | 0.020 |
Why?
|
| Infant | 3 | 2012 | 12286 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2011 | 13 | 0.020 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2011 | 15 | 0.020 |
Why?
|
| Methylmalonic Acid | 1 | 2011 | 14 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 1102 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2011 | 46 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2013 | 302 | 0.020 |
Why?
|
| Peroxidase | 1 | 2011 | 61 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 513 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 170 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6359 | 0.020 |
Why?
|
| Hexoses | 1 | 2009 | 11 | 0.020 |
Why?
|
| Ketone Bodies | 1 | 2009 | 45 | 0.020 |
Why?
|
| Lactates | 1 | 2009 | 89 | 0.020 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2009 | 4 | 0.020 |
Why?
|
| Nitrogen Isotopes | 1 | 2009 | 54 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 2009 | 75 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4263 | 0.020 |
Why?
|
| C-Peptide | 1 | 2009 | 109 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1011 | 0.020 |
Why?
|
| Kidney | 1 | 2015 | 1337 | 0.020 |
Why?
|
| Cysteine | 1 | 2009 | 133 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 273 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1005 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2009 | 99 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 412 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 3050 | 0.020 |
Why?
|
| Metabolomics | 1 | 2011 | 397 | 0.020 |
Why?
|
| Cell Division | 1 | 2009 | 779 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1926 | 0.020 |
Why?
|
| Sulfur Compounds | 1 | 2007 | 4 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2007 | 14 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 999 | 0.020 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2006 | 40 | 0.020 |
Why?
|
| Capillaries | 1 | 2006 | 66 | 0.020 |
Why?
|
| Milk, Human | 1 | 2009 | 296 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 867 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 661 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2012 | 13819 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3510 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 19033 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 2837 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6198 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12087 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 5772 | 0.010 |
Why?
|